Search all trials

Find therapies in clinical trials near you – page 10

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Bladder transitional cell carcinoma

Not recruiting

Registered drugNo placebo

Study on TAR-200 and Cetrelimab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Who Have Not Received BCG Treatment

Registered drugNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Cetrelimab

Contact Research Centre

Idiopathic pulmonary fibrosis

Not recruiting

InvestigationalNo placebo

Long-Term Study of BI 1015550 for Patients with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis

InvestigationalNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Bi 1015550

Contact Research Centre

B-cell lymphoma+1

Not recruiting

Registered drugNo placebo

Study on Epcoritamab, Rituximab, and Lenalidomide for Adults with Untreated Follicular Lymphoma

Registered drugNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Cyclophosphamide

Contact Research Centre

Squamous cell carcinoma of head and neck

Not recruiting

Registered drugNo placebo

Study of Lenvatinib and Pembrolizumab for Patients with Recurrent or Metastatic Head and Neck Cancer After Platinum and Immunotherapy Treatment

Registered drugNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Non-obstructive cardiomyopathy

Not recruiting

Investigational

Study on Mavacamten for Adults with Non-obstructive Hypertrophic Cardiomyopathy

Investigational

Portugal

Participants:18–64 years · 65+ years
Substances:Mavacamten

Contact Research Centre

Chronic myeloid leukaemia

Not recruiting

Registered drugNo placebo

Study Comparing Asciminib with Other Drug Combinations for Adults with Newly Diagnosed Chronic Myeloid Leukemia

Registered drugNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Bosutinib

Contact Research Centre

Bladder transitional cell carcinoma

Not recruiting

InvestigationalNo placebo

Study on TAR-200 and Cetrelimab for High-Risk Bladder Cancer Patients Not Responding to BCG and Unable or Unwilling to Have Surgery

InvestigationalNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Cetrelimab

Contact Research Centre

Diffuse large B-cell lymphoma

Not recruiting

Registered drug

Study on Acalabrutinib with Drug Combination for Patients 75 and Older with Untreated Diffuse Large B-Cell Lymphoma

Registered drug

Portugal

Participants:18–64 years · 65+ years
Substances:Acalabrutinib

Contact Research Centre

Rheumatoid arthritis

Not recruiting

InvestigationalNo placebo

Study on the Effects of Folate-Based Liposomes with Methotrexate for Patients with Moderate-to-Severe Rheumatoid Arthritis

InvestigationalNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Methotrexate

Contact Research Centre

Colitis ulcerative

Not recruiting

Investigational

Study on the Effects of Guselkumab and Golimumab for Patients with Moderate to Severe Ulcerative Colitis

Investigational

Portugal

Participants:18–64 years
Substances:Golimumab

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study of Immunotherapy Combinations with GSK4428859, Dostarlimab, and GSK6097608 for Patients with Advanced Non-Small Cell Lung Cancer

Registered drugNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Dostarlimab

Contact Research Centre

Pulmonary arterial hypertension

Not recruiting

InvestigationalNo placebo

Study on Long-term Safety of Seralutinib for Patients with Pulmonary Arterial Hypertension

InvestigationalNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Seralutinib

Contact Research Centre

Find therapies in clinical trials near you – page 10

145 trials match your criteria

Bladder transitional cell carcinoma

Study on TAR-200 and Cetrelimab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Who Have Not Received BCG Treatment

Idiopathic pulmonary fibrosis

Long-Term Study of BI 1015550 for Patients with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis

B-cell lymphoma+1

Study on Epcoritamab, Rituximab, and Lenalidomide for Adults with Untreated Follicular Lymphoma

Squamous cell carcinoma of head and neck

Study of Lenvatinib and Pembrolizumab for Patients with Recurrent or Metastatic Head and Neck Cancer After Platinum and Immunotherapy Treatment

Non-obstructive cardiomyopathy

Study on Mavacamten for Adults with Non-obstructive Hypertrophic Cardiomyopathy

Chronic myeloid leukaemia

Study Comparing Asciminib with Other Drug Combinations for Adults with Newly Diagnosed Chronic Myeloid Leukemia

Bladder transitional cell carcinoma

Study on TAR-200 and Cetrelimab for High-Risk Bladder Cancer Patients Not Responding to BCG and Unable or Unwilling to Have Surgery

Diffuse large B-cell lymphoma

Study on Acalabrutinib with Drug Combination for Patients 75 and Older with Untreated Diffuse Large B-Cell Lymphoma

Rheumatoid arthritis

Study on the Effects of Folate-Based Liposomes with Methotrexate for Patients with Moderate-to-Severe Rheumatoid Arthritis

Colitis ulcerative

Study on the Effects of Guselkumab and Golimumab for Patients with Moderate to Severe Ulcerative Colitis

Non-small cell lung cancer

Study of Immunotherapy Combinations with GSK4428859, Dostarlimab, and GSK6097608 for Patients with Advanced Non-Small Cell Lung Cancer

Pulmonary arterial hypertension

Study on Long-term Safety of Seralutinib for Patients with Pulmonary Arterial Hypertension

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.